Patents Assigned to Afraxis, Inc.
  • Distributed anatomical image analysis
    Patent number: 8977024
    Abstract: Disclosed are platforms, systems, computer program products for high throughput, distributed screening and analysis of images by a plurality of human image analysts, including methods of using the same.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: March 10, 2015
    Assignee: Afraxis, Inc.
    Inventors: Christopher Steven Rex, Steven Ray Boikess
  • 8-(2'-HETEROCYCYL)PYRIDO[2.3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130338153
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
    Type: Application
    Filed: June 10, 2011
    Publication date: December 19, 2013
    Applicant: AFRAXIS, INC.
    Inventors: David Campbell, Sergio G. Duron, Benedikt Vollrath, Warren Wade
  • 6-(SULFONYLARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130252966
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 26, 2013
    Applicant: AFRAXIS, INC.
    Inventors: David Campbell, Sergio G. Duron, Benedikt Vollrath, Warren Wade
  • 8-(SULFONYLBENZYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130252967
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
    Type: Application
    Filed: June 10, 2011
    Publication date: September 26, 2013
    Applicant: AFRAXIS, INC.
    Inventors: David Campbell, Sergio G. Duron, Benedikt Vollrath, Warren Wade
  • 6-(ETHYNYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130245012
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
    Type: Application
    Filed: June 10, 2011
    Publication date: September 19, 2013
    Applicant: AFRAXIS, INC.
    Inventors: David Campbell, Sergio G. Duron, Benedikt Vollrath, Warren Wade
  • 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130231348
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 5, 2013
    Applicant: AFRAXIS, INC.
    Inventors: David Campbell, Sergio G. Duron, Benedikt Vollrath, Warren Wade
  • METHODS FOR TREATING NEUROLOGICAL CONDITIONS
    Publication number: 20130225575
    Abstract: Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from certain neurological conditions.
    Type: Application
    Filed: June 16, 2011
    Publication date: August 29, 2013
    Applicant: AFRAXIS, INC.
    Inventors: Jay Lichter, David Campbell, Sergio G. Duron, Benedikt Vollrath
  • PAK INHIBITORS FOR THE TREATMENT OF CANCER
    Publication number: 20130158043
    Abstract: Provided herein are methods of utilizing PAK inhibitors for the treatment of cancer. Further provided herein are compounds and formulations utilized for the treatment of cancer.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 20, 2013
    Applicant: AFRAXIS, INC.
    Inventor: Afraxis, Inc.
  • PAK INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS
    Publication number: 20130116263
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of cell proliferative disorders and/or CNS disorders.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 9, 2013
    Applicant: AFRAXIS, INC.
    Inventor: AFRAXIS, INC.
  • METHODS FOR TREATING AUTISM
    Publication number: 20130096115
    Abstract: Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from autism.
    Type: Application
    Filed: December 21, 2010
    Publication date: April 18, 2013
    Applicant: AFRAXIS, INC.
    Inventors: Jay Lichter, David Campbell, Benedikt Vollrath, Sergio G. Durón
  • METHODS FOR TREATING MILD COGNITIVE IMPAIRMENT
    Publication number: 20130059824
    Abstract: Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Mild Cognitive Impairment.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 7, 2013
    Applicant: AFRAXis, Inc.
    Inventors: Jay Lichter, David Campbell, Benedikt Vollrath, Sergio G. Durón
  • 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
    Patent number: 8372970
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: February 12, 2013
    Assignee: Afraxis, Inc.
    Inventors: Benedikt Vollrath, David Campbell, Sergio G. Durón, Warren Wade
  • 8-ETHYL-6-(ARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20130035335
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
    Type: Application
    Filed: September 18, 2012
    Publication date: February 7, 2013
    Applicant: aFRAXis, Inc.
    Inventor: aFRAXis, Inc.
  • PYRROLOPYRAZOLES FOR TREATING CNS DISORDERS
    Publication number: 20120283296
    Abstract: Provided herein are methods of utilizing PAK inhibitors for the treatment of CNS disorders.
    Type: Application
    Filed: October 6, 2010
    Publication date: November 8, 2012
    Applicant: aFRAXis, Inc.
    Inventors: David Campbell, Sergio G. Durón, Benedikt Vollrath
  • 8-ETHYL-6-(ARYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20120270866
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders.
    Type: Application
    Filed: October 8, 2010
    Publication date: October 25, 2012
    Applicant: aFRAXis Inc.
    Inventors: Benedikt Vollrath, Daivd Campbell, Sergio G. Durón, Warren Wade
  • METHODS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20120270844
    Abstract: Provided herein arc PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Alzheimer's disease.
    Type: Application
    Filed: October 8, 2010
    Publication date: October 25, 2012
    Applicant: aFRAXis, Inc.
    Inventors: Jay Lichter, Benedikt Vollrath, David Campbell, Sergio G. Durón
  • METHODS FOR TREATING SCHIZOPHRENIA
    Publication number: 20120184547
    Abstract: Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from schizophrenia.
    Type: Application
    Filed: July 16, 2010
    Publication date: July 19, 2012
    Applicant: aFRAXis, Inc.
    Inventors: Jay Lichter, David Campbell, Benedikt Vollrath, Sergio G. Durón
  • COMPOUNDS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
    Publication number: 20120046283
    Abstract: Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of neuropsychiatric conditions.
    Type: Application
    Filed: December 18, 2009
    Publication date: February 23, 2012
    Applicant: AFRAXIS INC.
    Inventors: David Campbell, Sergio G. Durón, Benedikt Vollrath, Warren Wade